RPS14 and myelodysplastic syndrome: Finally, we performed quantitative RT-PCR assays to quantify the expression of two genes already known as prognostic in MDS: WT1 and RPS14. The WT1 (Wilms’ tumor) is a tumor suppressor gene [22] whose over-expression well correlates with blasts percentage [23, 24].